Literature DB >> 6806370

Heterogeneity of human monocyte subsets in the promotion of B cell colonies and the role of interleukin 1.

R L Whisler, Y G Newhouse, L B Lachman.   

Abstract

The abilities of human peripheral blood mononuclear-phagocyte (M phi) subpopulations and of interleukin 1 (IL 1) to support human B cell colony formation in semisolid cultures stimulated by staph protein A were analyzed. Human M phi subsets enriched for complement receptors (CR) effectively functioned as accessory cells supporting colony growth, whereas the responses obtained with CR-depleted M phi were 4.6-fold less. In experiments analyzing IL 1 production, CR-enriched M phi secreted four to 12 fold greater amounts of basal and stimulated IL 1 than CR-depleted M phi. Also, the addition of IL 1 to CR-depleted M phi resulted in a fourfold increase of colony numbers. The responses of cultures containing CR-depleted M phi plus IL 1, however, remained 30% less than those observed for cultures supplemented with CR-enriched M phi. Other studies showed that IL 1 was unable to substitute for M phi; the responses of cultures containing IL 1 and B cells were reduced 10-fold compared to cultures supplemented with autologous M phi. These findings indicate that human M phi subsets exist that differ in their ability to function as accessory cells. Although IL 1 can collaborate with certain M phi subsets to restore their accessory cell function, it cannot replace intact M phi. Thus, it is possible that other monokines or lymphokines play a role in M phi accessory cell function.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6806370

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Comparison of human monocytes isolated by elutriation and adherence suggests that heterogeneity may reflect a continuum of maturation/activation states.

Authors:  I Dransfield; D Corcoran; L J Partridge; N Hogg; D R Burton
Journal:  Immunology       Date:  1988-03       Impact factor: 7.397

Review 2.  The role of complement in the induction and regulation of immune responses.

Authors:  T G Egwang; A D Befus
Journal:  Immunology       Date:  1984-02       Impact factor: 7.397

3.  Long-term growth of human B cells and their use in a microassay for B-cell growth factor.

Authors:  A L Maizel; J W Morgan; S R Mehta; N M Kouttab; J M Bator; C G Sahasrabuddhe
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

4.  Interleukin-2 and interferon-gamma recruit different subsets of human peripheral blood monocytes to secrete interleukin-1 beta and tumour necrosis factor-alpha.

Authors:  F Herrmann; G Gebauer; A Lindemann; M Brach; R Mertelsmann
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

5.  Characterization of a human blood monocyte subset with low peroxidase activity.

Authors:  Y Akiyama; P J Miller; G B Thurman; R H Neubauer; C Oliver; T Favilla; J A Beman; R K Oldham; H C Stevenson
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

6.  Ia antigen expression and IL-1 activity in murine tumour-associated macrophages.

Authors:  G Peri; V Rossi; G Taraboletti; A Erroi; A Mantovani
Journal:  Immunology       Date:  1986-12       Impact factor: 7.397

7.  Normal human alveolar macrophages obtained by bronchoalveolar lavage have a limited capacity to release interleukin-1.

Authors:  M D Wewers; S I Rennard; A J Hance; P B Bitterman; R G Crystal
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

8.  Quantification of interleukin-1 in nasal polyps from patients with chronic sinusitis.

Authors:  Y Liu; Y Hamaguchi; M Taya; Y Sakakura
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

9.  Receptors for the third component of complement: their association with maturation stage in non-Hodgkin lymphomas (NHL) and their possible implication with the development of follicular structures.

Authors:  R Greil; C Gattringer; T Schulz; W Knapp; T Radaskiewicz; M P Dierich; H Huber
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.